Provided by Tiger Fintech (Singapore) Pte. Ltd.

Eterna Therapeutics Inc.

0.2160
+0.01115.42%
Post-market: 0.2061-0.0099-4.58%17:59 EDT
Volume:210.79K
Turnover:43.59K
Market Cap:13.43M
PE:-0.07
High:0.2200
Open:0.2040
Low:0.1900
Close:0.2049
Loading ...
Aug 19, 2023

Correspondence

Form CORRESP - Correspondence
Aug 11, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 10, 2023

Major Issues Report

Form 8-K - Current report
Aug 03, 2023

Major Issues Report

Form 8-K - Current report
Jul 27, 2023

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Jul 21, 2023

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Jul 18, 2023

Major Issues Report

Form 8-K - Current report
Jul 13, 2023

Major Issues Report

Form 8-K - Current report
Jul 11, 2023

Major Issues Report

Form 8-K - Current report
Jun 20, 2023

Major Issues Report

Form 8-K - Current report
May 11, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 05, 2023

Major Issues Report

Form 8-K - Current report
May 02, 2023

Major Issues Report

Form 8-K - Current report
Apr 20, 2023

Correspondence

Form CORRESP - Correspondence
Apr 17, 2023

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933
Apr 11, 2023

Major Issues Report

Form 8-K - Current report
Apr 04, 2023

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Mar 20, 2023

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 20, 2023

Major Issues Report

Form 8-K - Current report
Mar 06, 2023

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]